Integral Ad Science (NASDAQ:IAS) Posts Earnings Results, Beats Estimates By $0.03 EPS

Integral Ad Science (NASDAQ:IASGet Free Report) posted its quarterly earnings results on Tuesday. The company reported $0.06 EPS for the quarter, beating the consensus estimate of $0.03 by $0.03, Briefing.com reports. Integral Ad Science had a net margin of 1.53% and a return on equity of 0.84%. The company had revenue of $134.30 million for the quarter, compared to analyst estimates of $131.27 million. During the same period in the prior year, the company earned $0.07 earnings per share. The firm’s revenue was up 14.4% on a year-over-year basis. Integral Ad Science updated its FY 2024 guidance to EPS and its Q1 2024 guidance to EPS.

Integral Ad Science Stock Performance

Shares of NASDAQ:IAS traded up $0.34 during midday trading on Thursday, hitting $10.35. The stock had a trading volume of 2,971,754 shares, compared to its average volume of 1,419,978. The company has a market capitalization of $1.63 billion, a PE ratio of 250.31, a P/E/G ratio of 1.72 and a beta of 1.82. Integral Ad Science has a 1 year low of $9.44 and a 1 year high of $20.88. The stock has a 50 day moving average price of $15.19 and a two-hundred day moving average price of $13.91. The company has a current ratio of 3.47, a quick ratio of 3.47 and a debt-to-equity ratio of 0.20.

Wall Street Analyst Weigh In

IAS has been the topic of several recent analyst reports. Piper Sandler lowered their target price on shares of Integral Ad Science from $20.00 to $18.00 and set an “overweight” rating on the stock in a research note on Wednesday. Truist Financial cut their price objective on shares of Integral Ad Science from $26.00 to $17.00 and set a “buy” rating for the company in a report on Wednesday. BMO Capital Markets cut their price objective on shares of Integral Ad Science from $18.00 to $16.00 and set an “outperform” rating for the company in a report on Wednesday. Bank of America began coverage on shares of Integral Ad Science in a report on Thursday, January 11th. They set a “buy” rating and a $19.00 price target for the company. Finally, Barclays cut their price target on shares of Integral Ad Science from $17.00 to $16.00 and set an “equal weight” rating for the company in a report on Wednesday. Three research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $18.29.

Read Our Latest Research Report on IAS

Insider Buying and Selling

In related news, major shareholder Vep Group, Llc sold 11,000,000 shares of the business’s stock in a transaction dated Thursday, December 7th. The shares were sold at an average price of $14.00, for a total transaction of $154,000,000.00. Following the sale, the insider now owns 66,660,001 shares of the company’s stock, valued at $933,240,014. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other Integral Ad Science news, major shareholder Vep Group, Llc sold 11,000,000 shares of the company’s stock in a transaction dated Thursday, December 7th. The shares were sold at an average price of $14.00, for a total value of $154,000,000.00. Following the sale, the insider now owns 66,660,001 shares of the company’s stock, valued at $933,240,014. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Lisa Utzschneider sold 13,113 shares of the company’s stock in a transaction dated Tuesday, February 6th. The shares were sold at an average price of $15.79, for a total transaction of $207,054.27. Following the completion of the sale, the chief executive officer now directly owns 148,657 shares in the company, valued at approximately $2,347,294.03. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 12,721,781 shares of company stock valued at $178,129,079. Corporate insiders own 2.00% of the company’s stock.

Hedge Funds Weigh In On Integral Ad Science

Institutional investors have recently modified their holdings of the company. Ameritas Investment Partners Inc. increased its position in Integral Ad Science by 92.1% during the first quarter. Ameritas Investment Partners Inc. now owns 2,499 shares of the company’s stock worth $34,000 after purchasing an additional 1,198 shares during the last quarter. Tower Research Capital LLC TRC raised its stake in shares of Integral Ad Science by 493.4% in the 3rd quarter. Tower Research Capital LLC TRC now owns 8,581 shares of the company’s stock valued at $62,000 after acquiring an additional 7,135 shares during the period. Amundi purchased a new position in shares of Integral Ad Science in the 4th quarter valued at $94,000. UBS Group AG raised its stake in shares of Integral Ad Science by 119,733.3% in the 4th quarter. UBS Group AG now owns 10,785 shares of the company’s stock valued at $95,000 after acquiring an additional 10,776 shares during the period. Finally, Trexquant Investment LP purchased a new position in shares of Integral Ad Science in the 3rd quarter valued at $98,000. Institutional investors and hedge funds own 95.78% of the company’s stock.

About Integral Ad Science

(Get Free Report)

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Germany, Italy, Singapore, Australia, France, Japan, and India. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

Read More

Earnings History for Integral Ad Science (NASDAQ:IAS)

Receive News & Ratings for Integral Ad Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Ad Science and related companies with MarketBeat.com's FREE daily email newsletter.